WuXi Bio ex­pands US pres­ence; Fu­ji­Film boosts au­toin­jec­tor ser­vices; Spec­tron­Rx to make prostate can­cer ra­di­oli­gand

Wel­come to End­points News’ man­u­fac­tur­ing news briefs, where we bring you es­sen­tial up­dates on new builds, col­lab­o­ra­tions, re­calls and more.

WuXi Bi­o­log­ics is ex­pand­ing its fa­cil­i­ty in Worces­ter, MA, by 12,000 liters for com­mer­cial drug sub­stance pro­duc­tion to a to­tal of 36,000 liters. An­nounced on Mon­day, con­struc­tion of the 189,500 square-foot fa­cil­i­ty is un­der­way, which was orig­i­nal­ly planned to on­ly house 24,000 liters. The site will be op­er­a­tional in 2025, with a GMP re­lease in 2026, adding 200 new jobs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER